| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
870 |
747 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,063 |
909 |
$39K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
509 |
508 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
181 |
179 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
310 |
227 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
101 |
99 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
265 |
239 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
102 |
94 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
909 |
760 |
$1K |
| 87634 |
|
60 |
59 |
$991.85 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
68 |
68 |
$847.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
254 |
227 |
$269.07 |
| 93000 |
|
12 |
12 |
$145.93 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
25 |
$135.00 |
| 36415 |
Collection of venous blood by venipuncture |
94 |
91 |
$10.60 |
| 94760 |
|
30 |
29 |
$0.65 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
63 |
63 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
66 |
66 |
$0.00 |